Ratings Trulieve Cannabis Corp.

Equities

TRUL

CA89788C1041

Market Closed - Canadian Securities Exchange Other stock markets 03:59:01 2024-04-18 pm EDT			5-day change	1st Jan Change
15.72 ^CAD	0.00%		-4.90%	+129.49%

Apr. 02	Pot producers climb as recreational cannabis to go on Florida ballot	RE
Mar. 26	Trulieve Cannabis Brief: Opening Medical Cannabis Dispensary in Cocoa Beach, Florida	MT

Summary

Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
Analysts covering this company mostly recommend stock overweighting or purchase.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Over the past four months, analysts' average price target has been revised upwards significantly.
Analyst opinion has improved significantly over the past four months.

Weaknesses

With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
Low profitability weakens the company.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Pharmaceuticals

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
TRULIEVE CANNABIS CORP.	+129.49%	2.18B		C
CURALEAF HOLDINGS, INC.	+26.32%	3.74B		C-
GOODNESS GROWTH HOLDINGS, INC.	+68.25%	55.17M	-	-
ACREAGE HOLDINGS, INC.	+265.38%	54.09M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes